| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |